Halozyme Therapeutics Inc. Common Stock vs TTM Technologies Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.45 (market cap $12.58B), while TTM Technologies Inc. Common Stock trades at $121.37 (market cap $12.38B). The key difference: Halozyme Therapeutics Inc. Common Stock and TTM Technologies Inc. Common Stock are close in size by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, TTM Technologies Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and TTM Technologies Inc. Common Stock for 0 Days on average.
| HALO | TTMI | |
|---|---|---|
Market Cap | $12.58B | $12.38B |
Volume | 2,179,278 | 2,258,598 |
Sector | Health | Technology |
52-Week High | $115.22 | $221.47 |
52-Week Low | $61.63 | $53.58 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.49B | $12.97B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →TTM Technologies manufactures printed circuit boards, radio-frequency components, and electronics assemblies. Its products are used in aerospace, defense, automotive, data center, and communications equipment.
Read more on TTMI →